MedTrace Logo

IMRT Alone for Stage IB Nasopharyngeal Carcinoma Without High-Risk Features

NCT07376603 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 169

Last updated 2026-01-29

No results posted yet for this study

Summary

This observational study aims to evaluate the efficacy and safety of intensity-modulated radiotherapy (IMRT) alone in patients with stage IB nasopharyngeal carcinoma (NPC) without high-risk features. The primary objective is to determine the therapeutic effectiveness of this approach

Conditions

  • Nasopharyngeal Cancinoma (NPC)
  • Intensity-modulated Radiotherapy
  • Stage IB

Interventions

RADIATION

IMRT along

All patients administered with definitive radiotherapy

Sponsors & Collaborators

  • Qiaojuan Guo

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-12
Primary Completion
2030-12-31
Completion
2030-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07376603 on ClinicalTrials.gov